Evaluation of the BodyGuardian End-to-end Remote Monitoring Platform in an Outpatient Heart Failure Population
Trial status: Open for Enrollment
Why is this study being done?
The overall objective of our research is to test, adapt, refine and validate the BodyGuardian technology and related end-to-end remote monitoring system to be used outside usual medical care environments to reduce hospital readmissions and facilitate independent living for HF patients. An important component of our overall strategy for continued development and refinement of the remote monitoring system is the incorporation of iterative behavioral evaluations to facilitate assessment and refinement in order to optimize adherence, utilization, and usability for patients as well as efficiency and functionality for providers.
Who is eligible to participate?
- Stable NYHA Class I-III HF (defined as no admissions for > 1 year)
- Recruited from the Mayo Heart Failure Clinic, including 15 men and 15 women
- Age > 50 years
- Reside in Olmsted County
- Hospital admission for HF within past year
- Overall life expectancy < 1 year
- Pregnancy or women able to become pregnant
- Skin allergy to adhesives
- Inadequate cell phone coverage (international patients or international travel during study period)
- Documented EF of >40%